BC
OCDX

Bridgefront Capital’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bridgefront Capital’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,196
Closed -$246K – 471
2022
Q1 		$246K Buy
+13,196
New +$237K 0.3% 156

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bridgefront Capital's OCDX Position: Q2 2022 in Review

Bridgefront Capital sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 13,196 shares — an estimated $246K sold.

Bridgefront Capital first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $246K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Bridgefront Capital reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Bridgefront Capital sold 13,196 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $246K.
  • Bridgefront Capital first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Bridgefront Capital's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $246K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Bridgefront Capital's 13F filing for Q2 2022, filed 12 Aug 2022.